Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5270697
Max Phase: Preclinical
Molecular Formula: C39H68N18O11S4
Molecular Weight: 1093.36
Associated Items:
ID: ALA5270697
Max Phase: Preclinical
Molecular Formula: C39H68N18O11S4
Molecular Weight: 1093.36
Associated Items:
Canonical SMILES: CC[C@H](C)[C@@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]2CSSC[C@H](NC1=O)C(=O)N[C@H](C(N)=O)CSSC[C@H](NC(=O)[C@@H](N)CC(N)=O)C(=O)N2
Standard InChI: InChI=1S/C39H68N18O11S4/c1-3-17(2)28-37(68)56-25-16-72-71-15-24(55-36(67)23(54-30(61)18(40)12-27(42)59)14-70-69-13-22(29(43)60)53-35(25)66)34(65)51-20(7-5-11-49-39(46)47)31(62)50-19(6-4-10-48-38(44)45)32(63)52-21(33(64)57-28)8-9-26(41)58/h17-25,28H,3-16,40H2,1-2H3,(H2,41,58)(H2,42,59)(H2,43,60)(H,50,62)(H,51,65)(H,52,63)(H,53,66)(H,54,61)(H,55,67)(H,56,68)(H,57,64)(H4,44,45,48)(H4,46,47,49)/t17-,18-,19-,20-,21-,22-,23-,24-,25-,28-/m0/s1
Standard InChI Key: XCYVWYJISHLXCV-DKWPCZOMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1093.36 | Molecular Weight (Monoisotopic): 1092.4198 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Brust A, Croker DE, Colless B, Ragnarsson L, Andersson Å, Jain K, Garcia-Caraballo S, Castro J, Brierley SM, Alewood PF, Lewis RJ.. (2016) Conopeptide-Derived κ-Opioid Agonists (Conorphins): Potent, Selective, and Metabolic Stable Dynorphin A Mimetics with Antinociceptive Properties., 59 (6): [PMID:26859603] [10.1021/acs.jmedchem.5b00911] |
Source(1):